Tag Archives: DeNovo Sciences

December 2015—DeNovo Sciences announced that the company will operate under the name Celsee Diagnostics, effective immediately.

July 2014—DeNovo Sciences published “A novel microchannel-based device to capture and analyze circulating tumor cells (CTCs) of breast cancer.” DeNovo’s scientific team explored microfluidic capture techniques for isolating CTCs, which resulted in the development of proprietary technology to accomplish rare cell capture and analysis.